Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia
Note: employees of the Institute are marked with an asterisk (*) in the list of authors.
Web of Science ,
Scopus
Authors
* Lioznov D.A., * Amosova I.V., Sheetikov S.A., Zornikova K.V., Serdyuk Y., Efimov G.A., Tsyferov M., Khmelevskii M., Afanasiev A., Khomyakova N., Zubkov D. Tikhonov A., Zhu T., Barreto L., Dzutseva V.
Publication type
Journal article
Indexed in
Web of Science ,
Scopus Info:
Published in
PLoS ONE
Year of publication
2023
Volume
18
Number
3
Pages
e0278878